nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS2—stomach cancer	0.544	1	CbGaD
Nabumetone—MPO—blood vessel—stomach cancer	0.00614	0.107	CbGeAlD
Nabumetone—Naproxen—AKR1C3—stomach cancer	0.00357	0.751	CrCbGaD
Nabumetone—MPO—hematopoietic system—stomach cancer	0.00327	0.0569	CbGeAlD
Nabumetone—MPO—epithelium—stomach cancer	0.00299	0.052	CbGeAlD
Nabumetone—PTGS1—blood vessel—stomach cancer	0.00291	0.0507	CbGeAlD
Nabumetone—PTGS2—blood vessel—stomach cancer	0.00279	0.0485	CbGeAlD
Nabumetone—MPO—pancreas—stomach cancer	0.00266	0.0464	CbGeAlD
Nabumetone—PTGS2—gall bladder—stomach cancer	0.00262	0.0456	CbGeAlD
Nabumetone—MPO—lymphoid tissue—stomach cancer	0.0023	0.0401	CbGeAlD
Nabumetone—MPO—digestive system—stomach cancer	0.00227	0.0396	CbGeAlD
Nabumetone—MPO—bone marrow—stomach cancer	0.0021	0.0365	CbGeAlD
Nabumetone—MPO—endocrine gland—stomach cancer	0.00188	0.0327	CbGeAlD
Nabumetone—CYP1A2—hematopoietic system—stomach cancer	0.00179	0.0312	CbGeAlD
Nabumetone—MPO—liver—stomach cancer	0.00169	0.0295	CbGeAlD
Nabumetone—PTGS1—hematopoietic system—stomach cancer	0.00155	0.027	CbGeAlD
Nabumetone—PTGS2—hematopoietic system—stomach cancer	0.00148	0.0258	CbGeAlD
Nabumetone—PTGS1—epithelium—stomach cancer	0.00142	0.0247	CbGeAlD
Nabumetone—PTGS1—smooth muscle tissue—stomach cancer	0.00137	0.0238	CbGeAlD
Nabumetone—PTGS2—epithelium—stomach cancer	0.00136	0.0236	CbGeAlD
Nabumetone—PTGS2—smooth muscle tissue—stomach cancer	0.00131	0.0227	CbGeAlD
Nabumetone—MPO—lymph node—stomach cancer	0.0013	0.0226	CbGeAlD
Nabumetone—CYP1A2—digestive system—stomach cancer	0.00125	0.0217	CbGeAlD
Nabumetone—PTGS2—pancreas—stomach cancer	0.00121	0.021	CbGeAlD
Nabumetone—PTGS1—digestive system—stomach cancer	0.00108	0.0188	CbGeAlD
Nabumetone—PTGS2—lymphoid tissue—stomach cancer	0.00104	0.0182	CbGeAlD
Nabumetone—PTGS2—digestive system—stomach cancer	0.00103	0.018	CbGeAlD
Nabumetone—CYP1A2—endocrine gland—stomach cancer	0.00103	0.0179	CbGeAlD
Nabumetone—PTGS2—bone marrow—stomach cancer	0.000951	0.0166	CbGeAlD
Nabumetone—CYP1A2—liver—stomach cancer	0.000928	0.0161	CbGeAlD
Nabumetone—PTGS1—endocrine gland—stomach cancer	0.000892	0.0155	CbGeAlD
Nabumetone—PTGS2—endocrine gland—stomach cancer	0.000852	0.0148	CbGeAlD
Nabumetone—PTGS2—liver—stomach cancer	0.000768	0.0134	CbGeAlD
Nabumetone—Naproxen—PTGS2—stomach cancer	0.000626	0.132	CrCbGaD
Nabumetone—PTGS1—lymph node—stomach cancer	0.000616	0.0107	CbGeAlD
Nabumetone—PTGS2—lymph node—stomach cancer	0.000589	0.0103	CbGeAlD
Nabumetone—Naproxen—ALB—stomach cancer	0.000558	0.117	CrCbGaD
Nabumetone—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000301	0.000993	CcSEcCtD
Nabumetone—Palpitations—Capecitabine—stomach cancer	0.000301	0.000993	CcSEcCtD
Nabumetone—Loss of consciousness—Capecitabine—stomach cancer	0.0003	0.000988	CcSEcCtD
Nabumetone—Renal failure—Epirubicin—stomach cancer	0.000299	0.000985	CcSEcCtD
Nabumetone—Asthenia—Irinotecan—stomach cancer	0.000298	0.000983	CcSEcCtD
Nabumetone—Cough—Capecitabine—stomach cancer	0.000297	0.000981	CcSEcCtD
Nabumetone—Stomatitis—Epirubicin—stomach cancer	0.000296	0.000977	CcSEcCtD
Nabumetone—Jaundice—Epirubicin—stomach cancer	0.000296	0.000977	CcSEcCtD
Nabumetone—Dysuria—Doxorubicin—stomach cancer	0.000295	0.000972	CcSEcCtD
Nabumetone—Hypertension—Capecitabine—stomach cancer	0.000294	0.00097	CcSEcCtD
Nabumetone—Hypersensitivity—Fluorouracil—stomach cancer	0.000293	0.000967	CcSEcCtD
Nabumetone—Dry mouth—Docetaxel—stomach cancer	0.000293	0.000967	CcSEcCtD
Nabumetone—Haemoglobin—Methotrexate—stomach cancer	0.000293	0.000966	CcSEcCtD
Nabumetone—Haemorrhage—Methotrexate—stomach cancer	0.000292	0.000961	CcSEcCtD
Nabumetone—Haematuria—Epirubicin—stomach cancer	0.00029	0.000955	CcSEcCtD
Nabumetone—Confusional state—Docetaxel—stomach cancer	0.00029	0.000955	CcSEcCtD
Nabumetone—Anxiety—Capecitabine—stomach cancer	0.000289	0.000954	CcSEcCtD
Nabumetone—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000288	0.000949	CcSEcCtD
Nabumetone—Oedema—Docetaxel—stomach cancer	0.000287	0.000947	CcSEcCtD
Nabumetone—Anaphylactic shock—Docetaxel—stomach cancer	0.000287	0.000947	CcSEcCtD
Nabumetone—Weight increased—Doxorubicin—stomach cancer	0.000287	0.000946	CcSEcCtD
Nabumetone—Discomfort—Capecitabine—stomach cancer	0.000287	0.000945	CcSEcCtD
Nabumetone—Weight decreased—Doxorubicin—stomach cancer	0.000285	0.000941	CcSEcCtD
Nabumetone—Hyperglycaemia—Doxorubicin—stomach cancer	0.000284	0.000938	CcSEcCtD
Nabumetone—Diarrhoea—Irinotecan—stomach cancer	0.000284	0.000938	CcSEcCtD
Nabumetone—Dry mouth—Capecitabine—stomach cancer	0.000284	0.000936	CcSEcCtD
Nabumetone—Agranulocytosis—Epirubicin—stomach cancer	0.000284	0.000935	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—stomach cancer	0.000283	0.000932	CcSEcCtD
Nabumetone—Shock—Docetaxel—stomach cancer	0.000283	0.000932	CcSEcCtD
Nabumetone—Pruritus—Fluorouracil—stomach cancer	0.000282	0.000929	CcSEcCtD
Nabumetone—Thrombocytopenia—Docetaxel—stomach cancer	0.000281	0.000928	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—stomach cancer	0.000281	0.000926	CcSEcCtD
Nabumetone—Confusional state—Capecitabine—stomach cancer	0.000281	0.000925	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000279	0.000919	CcSEcCtD
Nabumetone—Oedema—Capecitabine—stomach cancer	0.000278	0.000917	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—stomach cancer	0.000276	0.000911	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—stomach cancer	0.000276	0.000909	CcSEcCtD
Nabumetone—Dizziness—Irinotecan—stomach cancer	0.000275	0.000906	CcSEcCtD
Nabumetone—Haemoglobin—Epirubicin—stomach cancer	0.000274	0.000904	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—stomach cancer	0.000274	0.000904	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—stomach cancer	0.000274	0.000904	CcSEcCtD
Nabumetone—Anorexia—Docetaxel—stomach cancer	0.000274	0.000903	CcSEcCtD
Nabumetone—Shock—Capecitabine—stomach cancer	0.000274	0.000902	CcSEcCtD
Nabumetone—Haemorrhage—Epirubicin—stomach cancer	0.000273	0.000899	CcSEcCtD
Nabumetone—Diarrhoea—Fluorouracil—stomach cancer	0.000272	0.000898	CcSEcCtD
Nabumetone—Thrombocytopenia—Capecitabine—stomach cancer	0.000272	0.000898	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—stomach cancer	0.000272	0.000896	CcSEcCtD
Nabumetone—Hyperhidrosis—Capecitabine—stomach cancer	0.000269	0.000887	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—stomach cancer	0.000268	0.000884	CcSEcCtD
Nabumetone—Anorexia—Capecitabine—stomach cancer	0.000265	0.000874	CcSEcCtD
Nabumetone—Vomiting—Irinotecan—stomach cancer	0.000264	0.000871	CcSEcCtD
Nabumetone—Dizziness—Fluorouracil—stomach cancer	0.000263	0.000868	CcSEcCtD
Nabumetone—Visual impairment—Epirubicin—stomach cancer	0.000263	0.000867	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—stomach cancer	0.000262	0.000865	CcSEcCtD
Nabumetone—Rash—Irinotecan—stomach cancer	0.000262	0.000864	CcSEcCtD
Nabumetone—Dermatitis—Irinotecan—stomach cancer	0.000262	0.000863	CcSEcCtD
Nabumetone—Chills—Methotrexate—stomach cancer	0.000262	0.000862	CcSEcCtD
Nabumetone—Headache—Irinotecan—stomach cancer	0.00026	0.000859	CcSEcCtD
Nabumetone—Insomnia—Docetaxel—stomach cancer	0.00026	0.000857	CcSEcCtD
Nabumetone—Paraesthesia—Docetaxel—stomach cancer	0.000258	0.000851	CcSEcCtD
Nabumetone—Erythema multiforme—Epirubicin—stomach cancer	0.000258	0.00085	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—stomach cancer	0.000258	0.000849	CcSEcCtD
Nabumetone—Dyspnoea—Docetaxel—stomach cancer	0.000256	0.000845	CcSEcCtD
Nabumetone—Somnolence—Docetaxel—stomach cancer	0.000255	0.000842	CcSEcCtD
Nabumetone—Tinnitus—Epirubicin—stomach cancer	0.000254	0.000839	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—stomach cancer	0.000254	0.000836	CcSEcCtD
Nabumetone—Vomiting—Fluorouracil—stomach cancer	0.000253	0.000835	CcSEcCtD
Nabumetone—Dyspepsia—Docetaxel—stomach cancer	0.000253	0.000834	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—stomach cancer	0.000252	0.000832	CcSEcCtD
Nabumetone—Insomnia—Capecitabine—stomach cancer	0.000252	0.00083	CcSEcCtD
Nabumetone—Rash—Fluorouracil—stomach cancer	0.000251	0.000828	CcSEcCtD
Nabumetone—Dermatitis—Fluorouracil—stomach cancer	0.000251	0.000827	CcSEcCtD
Nabumetone—Paraesthesia—Capecitabine—stomach cancer	0.00025	0.000824	CcSEcCtD
Nabumetone—Decreased appetite—Docetaxel—stomach cancer	0.00025	0.000824	CcSEcCtD
Nabumetone—Headache—Fluorouracil—stomach cancer	0.000249	0.000822	CcSEcCtD
Nabumetone—Dyspnoea—Capecitabine—stomach cancer	0.000248	0.000818	CcSEcCtD
Nabumetone—Fatigue—Docetaxel—stomach cancer	0.000248	0.000817	CcSEcCtD
Nabumetone—Nausea—Irinotecan—stomach cancer	0.000247	0.000814	CcSEcCtD
Nabumetone—Constipation—Docetaxel—stomach cancer	0.000246	0.00081	CcSEcCtD
Nabumetone—Dyspepsia—Capecitabine—stomach cancer	0.000245	0.000807	CcSEcCtD
Nabumetone—Chills—Epirubicin—stomach cancer	0.000245	0.000807	CcSEcCtD
Nabumetone—Arrhythmia—Epirubicin—stomach cancer	0.000244	0.000804	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—stomach cancer	0.000243	0.000802	CcSEcCtD
Nabumetone—Decreased appetite—Capecitabine—stomach cancer	0.000242	0.000797	CcSEcCtD
Nabumetone—Alopecia—Epirubicin—stomach cancer	0.000241	0.000795	CcSEcCtD
Nabumetone—Fatigue—Capecitabine—stomach cancer	0.00024	0.000791	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—stomach cancer	0.000239	0.000787	CcSEcCtD
Nabumetone—Constipation—Capecitabine—stomach cancer	0.000238	0.000784	CcSEcCtD
Nabumetone—Feeling abnormal—Docetaxel—stomach cancer	0.000237	0.000781	CcSEcCtD
Nabumetone—Nausea—Fluorouracil—stomach cancer	0.000236	0.00078	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—stomach cancer	0.000235	0.000776	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—stomach cancer	0.000235	0.000776	CcSEcCtD
Nabumetone—Gastrointestinal pain—Docetaxel—stomach cancer	0.000235	0.000775	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—stomach cancer	0.000235	0.000773	CcSEcCtD
Nabumetone—Flatulence—Epirubicin—stomach cancer	0.000234	0.000772	CcSEcCtD
Nabumetone—Tension—Epirubicin—stomach cancer	0.000233	0.000768	CcSEcCtD
Nabumetone—Nervousness—Epirubicin—stomach cancer	0.000231	0.00076	CcSEcCtD
Nabumetone—Feeling abnormal—Capecitabine—stomach cancer	0.000229	0.000756	CcSEcCtD
Nabumetone—Malaise—Methotrexate—stomach cancer	0.000229	0.000755	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—stomach cancer	0.000228	0.000752	CcSEcCtD
Nabumetone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000228	0.00075	CcSEcCtD
Nabumetone—Abdominal pain—Docetaxel—stomach cancer	0.000227	0.000749	CcSEcCtD
Nabumetone—Body temperature increased—Docetaxel—stomach cancer	0.000227	0.000749	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—stomach cancer	0.000227	0.000749	CcSEcCtD
Nabumetone—Chills—Doxorubicin—stomach cancer	0.000226	0.000747	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—stomach cancer	0.000226	0.000743	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—stomach cancer	0.000223	0.000735	CcSEcCtD
Nabumetone—Cough—Methotrexate—stomach cancer	0.000221	0.00073	CcSEcCtD
Nabumetone—Urticaria—Capecitabine—stomach cancer	0.000221	0.000729	CcSEcCtD
Nabumetone—Ill-defined disorder—Epirubicin—stomach cancer	0.00022	0.000727	CcSEcCtD
Nabumetone—Abdominal pain—Capecitabine—stomach cancer	0.00022	0.000725	CcSEcCtD
Nabumetone—Body temperature increased—Capecitabine—stomach cancer	0.00022	0.000725	CcSEcCtD
Nabumetone—Anaemia—Epirubicin—stomach cancer	0.00022	0.000724	CcSEcCtD
Nabumetone—Agitation—Epirubicin—stomach cancer	0.000218	0.00072	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—stomach cancer	0.000217	0.000714	CcSEcCtD
Nabumetone—Tension—Doxorubicin—stomach cancer	0.000216	0.000711	CcSEcCtD
Nabumetone—Malaise—Epirubicin—stomach cancer	0.000214	0.000706	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—stomach cancer	0.000213	0.000704	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—stomach cancer	0.000213	0.000704	CcSEcCtD
Nabumetone—Vertigo—Epirubicin—stomach cancer	0.000213	0.000703	CcSEcCtD
Nabumetone—Syncope—Epirubicin—stomach cancer	0.000213	0.000702	CcSEcCtD
Nabumetone—Leukopenia—Epirubicin—stomach cancer	0.000213	0.000701	CcSEcCtD
Nabumetone—Hypersensitivity—Docetaxel—stomach cancer	0.000212	0.000698	CcSEcCtD
Nabumetone—Palpitations—Epirubicin—stomach cancer	0.00021	0.000692	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—stomach cancer	0.000209	0.000689	CcSEcCtD
Nabumetone—Loss of consciousness—Epirubicin—stomach cancer	0.000209	0.000688	CcSEcCtD
Nabumetone—Cough—Epirubicin—stomach cancer	0.000207	0.000683	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—stomach cancer	0.000207	0.000683	CcSEcCtD
Nabumetone—Asthenia—Docetaxel—stomach cancer	0.000206	0.00068	CcSEcCtD
Nabumetone—Hypertension—Epirubicin—stomach cancer	0.000205	0.000676	CcSEcCtD
Nabumetone—Hypersensitivity—Capecitabine—stomach cancer	0.000205	0.000676	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—stomach cancer	0.000204	0.000672	CcSEcCtD
Nabumetone—Pruritus—Docetaxel—stomach cancer	0.000203	0.00067	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—stomach cancer	0.000203	0.00067	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—stomach cancer	0.000203	0.000669	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—stomach cancer	0.000202	0.000666	CcSEcCtD
Nabumetone—Anxiety—Epirubicin—stomach cancer	0.000201	0.000664	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—stomach cancer	0.0002	0.00066	CcSEcCtD
Nabumetone—Discomfort—Epirubicin—stomach cancer	0.0002	0.000659	CcSEcCtD
Nabumetone—Asthenia—Capecitabine—stomach cancer	0.0002	0.000658	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—stomach cancer	0.000198	0.000653	CcSEcCtD
Nabumetone—Dry mouth—Epirubicin—stomach cancer	0.000198	0.000652	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—stomach cancer	0.000197	0.000651	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—stomach cancer	0.000197	0.000651	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—stomach cancer	0.000197	0.00065	CcSEcCtD
Nabumetone—Pruritus—Capecitabine—stomach cancer	0.000197	0.000649	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—stomach cancer	0.000197	0.000649	CcSEcCtD
Nabumetone—Diarrhoea—Docetaxel—stomach cancer	0.000197	0.000648	CcSEcCtD
Nabumetone—Confusional state—Epirubicin—stomach cancer	0.000195	0.000644	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—stomach cancer	0.000194	0.00064	CcSEcCtD
Nabumetone—Oedema—Epirubicin—stomach cancer	0.000194	0.000639	CcSEcCtD
Nabumetone—Anaphylactic shock—Epirubicin—stomach cancer	0.000194	0.000639	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—stomach cancer	0.000193	0.000637	CcSEcCtD
Nabumetone—Cough—Doxorubicin—stomach cancer	0.000192	0.000632	CcSEcCtD
Nabumetone—Shock—Epirubicin—stomach cancer	0.000191	0.000629	CcSEcCtD
Nabumetone—Diarrhoea—Capecitabine—stomach cancer	0.00019	0.000628	CcSEcCtD
Nabumetone—Dizziness—Docetaxel—stomach cancer	0.00019	0.000627	CcSEcCtD
Nabumetone—Thrombocytopenia—Epirubicin—stomach cancer	0.00019	0.000626	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—stomach cancer	0.00019	0.000626	CcSEcCtD
Nabumetone—Hyperhidrosis—Epirubicin—stomach cancer	0.000187	0.000618	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—stomach cancer	0.000187	0.000618	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—stomach cancer	0.000186	0.000615	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—stomach cancer	0.000186	0.000613	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—stomach cancer	0.000185	0.000609	CcSEcCtD
Nabumetone—Anorexia—Epirubicin—stomach cancer	0.000185	0.000609	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—stomach cancer	0.000185	0.000609	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—stomach cancer	0.000184	0.000607	CcSEcCtD
Nabumetone—Dizziness—Capecitabine—stomach cancer	0.000184	0.000607	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—stomach cancer	0.000183	0.000603	CcSEcCtD
Nabumetone—Vomiting—Docetaxel—stomach cancer	0.000183	0.000602	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—stomach cancer	0.000182	0.000601	CcSEcCtD
Nabumetone—Rash—Docetaxel—stomach cancer	0.000181	0.000597	CcSEcCtD
Nabumetone—Dermatitis—Docetaxel—stomach cancer	0.000181	0.000597	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—stomach cancer	0.000181	0.000596	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—stomach cancer	0.00018	0.000594	CcSEcCtD
Nabumetone—Headache—Docetaxel—stomach cancer	0.00018	0.000594	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—stomach cancer	0.000179	0.000591	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—stomach cancer	0.000179	0.000591	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—stomach cancer	0.000179	0.000589	CcSEcCtD
Nabumetone—Vomiting—Capecitabine—stomach cancer	0.000177	0.000583	CcSEcCtD
Nabumetone—Shock—Doxorubicin—stomach cancer	0.000176	0.000582	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—stomach cancer	0.000176	0.000579	CcSEcCtD
Nabumetone—Rash—Capecitabine—stomach cancer	0.000175	0.000578	CcSEcCtD
Nabumetone—Insomnia—Epirubicin—stomach cancer	0.000175	0.000578	CcSEcCtD
Nabumetone—Dermatitis—Capecitabine—stomach cancer	0.000175	0.000578	CcSEcCtD
Nabumetone—Headache—Capecitabine—stomach cancer	0.000174	0.000575	CcSEcCtD
Nabumetone—Paraesthesia—Epirubicin—stomach cancer	0.000174	0.000574	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000173	0.000572	CcSEcCtD
Nabumetone—Dyspnoea—Epirubicin—stomach cancer	0.000173	0.00057	CcSEcCtD
Nabumetone—Somnolence—Epirubicin—stomach cancer	0.000172	0.000568	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—stomach cancer	0.000171	0.000564	CcSEcCtD
Nabumetone—Nausea—Docetaxel—stomach cancer	0.000171	0.000563	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—stomach cancer	0.000171	0.000563	CcSEcCtD
Nabumetone—Dyspepsia—Epirubicin—stomach cancer	0.000171	0.000563	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000169	0.000558	CcSEcCtD
Nabumetone—Decreased appetite—Epirubicin—stomach cancer	0.000168	0.000556	CcSEcCtD
Nabumetone—Fatigue—Epirubicin—stomach cancer	0.000167	0.000551	CcSEcCtD
Nabumetone—Constipation—Epirubicin—stomach cancer	0.000166	0.000546	CcSEcCtD
Nabumetone—Nausea—Capecitabine—stomach cancer	0.000165	0.000545	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—stomach cancer	0.000165	0.000542	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—stomach cancer	0.000164	0.00054	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—stomach cancer	0.000164	0.00054	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—stomach cancer	0.000162	0.000535	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—stomach cancer	0.000161	0.000531	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—stomach cancer	0.00016	0.000527	CcSEcCtD
Nabumetone—Feeling abnormal—Epirubicin—stomach cancer	0.00016	0.000527	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—stomach cancer	0.000159	0.000526	CcSEcCtD
Nabumetone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000158	0.000523	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—stomach cancer	0.000158	0.00052	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—stomach cancer	0.000156	0.000514	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—stomach cancer	0.000155	0.00051	CcSEcCtD
Nabumetone—Urticaria—Epirubicin—stomach cancer	0.000154	0.000508	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—stomach cancer	0.000153	0.000506	CcSEcCtD
Nabumetone—Body temperature increased—Epirubicin—stomach cancer	0.000153	0.000505	CcSEcCtD
Nabumetone—Abdominal pain—Epirubicin—stomach cancer	0.000153	0.000505	CcSEcCtD
Nabumetone—Hypersensitivity—Methotrexate—stomach cancer	0.000153	0.000503	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—stomach cancer	0.000149	0.00049	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—stomach cancer	0.000148	0.000487	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000147	0.000484	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—stomach cancer	0.000147	0.000483	CcSEcCtD
Nabumetone—Hypersensitivity—Epirubicin—stomach cancer	0.000143	0.000471	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—stomach cancer	0.000142	0.00047	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—stomach cancer	0.000142	0.000467	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—stomach cancer	0.000142	0.000467	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—stomach cancer	0.000142	0.000467	CcSEcCtD
Nabumetone—Asthenia—Epirubicin—stomach cancer	0.000139	0.000458	CcSEcCtD
Nabumetone—Pruritus—Epirubicin—stomach cancer	0.000137	0.000452	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—stomach cancer	0.000137	0.000452	CcSEcCtD
Nabumetone—Diarrhoea—Epirubicin—stomach cancer	0.000133	0.000437	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—stomach cancer	0.000132	0.000436	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—stomach cancer	0.000132	0.000434	CcSEcCtD
Nabumetone—Rash—Methotrexate—stomach cancer	0.000131	0.000431	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—stomach cancer	0.00013	0.00043	CcSEcCtD
Nabumetone—Headache—Methotrexate—stomach cancer	0.00013	0.000428	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—stomach cancer	0.000129	0.000424	CcSEcCtD
Nabumetone—Dizziness—Epirubicin—stomach cancer	0.000128	0.000423	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—stomach cancer	0.000127	0.000418	CcSEcCtD
Nabumetone—Vomiting—Epirubicin—stomach cancer	0.000123	0.000406	CcSEcCtD
Nabumetone—Nausea—Methotrexate—stomach cancer	0.000123	0.000406	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—stomach cancer	0.000123	0.000405	CcSEcCtD
Nabumetone—Rash—Epirubicin—stomach cancer	0.000122	0.000403	CcSEcCtD
Nabumetone—Dermatitis—Epirubicin—stomach cancer	0.000122	0.000403	CcSEcCtD
Nabumetone—Headache—Epirubicin—stomach cancer	0.000121	0.0004	CcSEcCtD
Nabumetone—Dizziness—Doxorubicin—stomach cancer	0.000119	0.000391	CcSEcCtD
Nabumetone—Nausea—Epirubicin—stomach cancer	0.000115	0.00038	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—stomach cancer	0.000114	0.000376	CcSEcCtD
Nabumetone—Rash—Doxorubicin—stomach cancer	0.000113	0.000373	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—stomach cancer	0.000113	0.000372	CcSEcCtD
Nabumetone—Headache—Doxorubicin—stomach cancer	0.000112	0.00037	CcSEcCtD
Nabumetone—Nausea—Doxorubicin—stomach cancer	0.000107	0.000351	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—CDKN1B—stomach cancer	8.21e-05	0.00091	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	8.21e-05	0.00091	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RBP1—stomach cancer	8.18e-05	0.000908	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—stomach cancer	8.06e-05	0.000894	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NDUFV1—stomach cancer	8.06e-05	0.000894	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NDUFS1—stomach cancer	8.06e-05	0.000894	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	7.88e-05	0.000874	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	7.83e-05	0.000868	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	7.76e-05	0.000861	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CA1—stomach cancer	7.7e-05	0.000853	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—FBP1—stomach cancer	7.7e-05	0.000853	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CKB—stomach cancer	7.7e-05	0.000853	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NDUFA2—stomach cancer	7.7e-05	0.000853	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	7.62e-05	0.000844	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	7.6e-05	0.000843	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	7.55e-05	0.000837	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—stomach cancer	7.52e-05	0.000834	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	7.4e-05	0.00082	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	7.39e-05	0.000819	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	7.39e-05	0.000819	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	7.39e-05	0.000819	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	7.3e-05	0.000809	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FBP1—stomach cancer	7.3e-05	0.000809	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLIN2—stomach cancer	7.24e-05	0.000802	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	7.23e-05	0.000802	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PGLS—stomach cancer	7.19e-05	0.000797	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—BLVRB—stomach cancer	7.19e-05	0.000797	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CA2—stomach cancer	7.04e-05	0.00078	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	7.03e-05	0.00078	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	7.03e-05	0.00078	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTP1—stomach cancer	7e-05	0.000776	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	6.98e-05	0.000774	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	6.91e-05	0.000766	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PGAM1—stomach cancer	6.86e-05	0.000761	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NT5E—stomach cancer	6.86e-05	0.000761	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPAP2A—stomach cancer	6.85e-05	0.00076	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	6.59e-05	0.000731	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALDH7A1—stomach cancer	6.54e-05	0.000726	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLCE1—stomach cancer	6.54e-05	0.000726	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PGAM1—stomach cancer	6.5e-05	0.000721	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	6.47e-05	0.000718	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	6.46e-05	0.000716	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTM1—stomach cancer	6.43e-05	0.000713	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	6.35e-05	0.000704	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MYC—stomach cancer	6.28e-05	0.000696	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—UMPS—stomach cancer	6.27e-05	0.000696	CbGpPWpGaD
Nabumetone—PTGS2—Disease—WIF1—stomach cancer	6.2e-05	0.000688	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	6.14e-05	0.000681	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	6.14e-05	0.000681	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NDUFA2—stomach cancer	6.11e-05	0.000677	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CKB—stomach cancer	6.11e-05	0.000677	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—FBP1—stomach cancer	6.11e-05	0.000677	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CA1—stomach cancer	6.11e-05	0.000677	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.03e-05	0.000668	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ACAD8—stomach cancer	6.02e-05	0.000667	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	5.97e-05	0.000662	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	5.93e-05	0.000658	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	5.88e-05	0.000652	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—stomach cancer	5.85e-05	0.000649	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PDHA1—stomach cancer	5.83e-05	0.000647	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ECHS1—stomach cancer	5.83e-05	0.000647	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPL13—stomach cancer	5.83e-05	0.000647	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPL18—stomach cancer	5.83e-05	0.000647	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLIN2—stomach cancer	5.74e-05	0.000637	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CA2—stomach cancer	5.59e-05	0.00062	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	5.58e-05	0.000619	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	5.53e-05	0.000613	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RNF43—stomach cancer	5.53e-05	0.000613	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—FADS1—stomach cancer	5.48e-05	0.000608	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TYMP—stomach cancer	5.48e-05	0.000608	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NT5E—stomach cancer	5.45e-05	0.000604	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PGAM1—stomach cancer	5.45e-05	0.000604	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS21—stomach cancer	5.44e-05	0.000603	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS15—stomach cancer	5.44e-05	0.000603	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GMPR2—stomach cancer	5.37e-05	0.000595	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.33e-05	0.000591	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.31e-05	0.000589	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDH7A1—stomach cancer	5.19e-05	0.000576	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLCE1—stomach cancer	5.19e-05	0.000576	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	5.18e-05	0.000574	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TP53—stomach cancer	5.16e-05	0.000572	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.15e-05	0.000571	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SREBF2—stomach cancer	5.13e-05	0.000569	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	5.12e-05	0.000568	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—RORA—stomach cancer	5.07e-05	0.000563	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.03e-05	0.000558	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—UMPS—stomach cancer	4.98e-05	0.000552	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SUCLG1—stomach cancer	4.91e-05	0.000544	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—IDH3B—stomach cancer	4.91e-05	0.000544	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALDOB—stomach cancer	4.75e-05	0.000527	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—stomach cancer	4.72e-05	0.000523	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.64e-05	0.000515	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PDHA1—stomach cancer	4.63e-05	0.000513	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ECHS1—stomach cancer	4.63e-05	0.000513	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NDUFV1—stomach cancer	4.56e-05	0.000506	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NDUFS1—stomach cancer	4.56e-05	0.000506	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ALDOB—stomach cancer	4.51e-05	0.0005	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.48e-05	0.000497	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.47e-05	0.000496	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	4.46e-05	0.000494	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALOX5—stomach cancer	4.42e-05	0.00049	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPL15—stomach cancer	4.42e-05	0.00049	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.39e-05	0.000487	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—FADS1—stomach cancer	4.35e-05	0.000483	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TYMP—stomach cancer	4.35e-05	0.000483	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DPYD—stomach cancer	4.35e-05	0.000482	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NPM1—stomach cancer	4.34e-05	0.000481	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.27e-05	0.000474	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RBP4—stomach cancer	4.19e-05	0.000465	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.18e-05	0.000463	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.18e-05	0.000463	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS26—stomach cancer	4.12e-05	0.000457	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPIA—stomach cancer	4.09e-05	0.000453	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SREBF2—stomach cancer	4.08e-05	0.000452	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PGLS—stomach cancer	4.07e-05	0.000451	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BLVRB—stomach cancer	4.07e-05	0.000451	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—RORA—stomach cancer	4.03e-05	0.000447	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	3.98e-05	0.000441	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	3.95e-05	0.000438	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.94e-05	0.000437	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPAP2A—stomach cancer	3.88e-05	0.00043	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTT1—stomach cancer	3.85e-05	0.000426	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2A6—stomach cancer	3.8e-05	0.000421	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDOB—stomach cancer	3.77e-05	0.000419	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	3.73e-05	0.000414	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKR1C3—stomach cancer	3.7e-05	0.00041	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.63e-05	0.000402	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ENO1—stomach cancer	3.6e-05	0.0004	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.56e-05	0.000395	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.55e-05	0.000394	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.54e-05	0.000393	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALOX5—stomach cancer	3.51e-05	0.000389	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.51e-05	0.000389	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKR1C3—stomach cancer	3.5e-05	0.000389	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS19—stomach cancer	3.5e-05	0.000389	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CKB—stomach cancer	3.46e-05	0.000383	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FBP1—stomach cancer	3.46e-05	0.000383	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NDUFA2—stomach cancer	3.46e-05	0.000383	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CA1—stomach cancer	3.46e-05	0.000383	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DPYD—stomach cancer	3.45e-05	0.000383	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ENO1—stomach cancer	3.42e-05	0.000379	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLIN2—stomach cancer	3.25e-05	0.00036	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CD44—stomach cancer	3.2e-05	0.000354	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CA2—stomach cancer	3.16e-05	0.000351	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.13e-05	0.000347	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.1e-05	0.000344	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS6—stomach cancer	3.1e-05	0.000344	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PGAM1—stomach cancer	3.08e-05	0.000342	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NT5E—stomach cancer	3.08e-05	0.000342	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTT1—stomach cancer	3.05e-05	0.000338	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD44—stomach cancer	3.03e-05	0.000336	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2A6—stomach cancer	3.02e-05	0.000335	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLCE1—stomach cancer	2.94e-05	0.000326	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDH7A1—stomach cancer	2.94e-05	0.000326	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKR1C3—stomach cancer	2.94e-05	0.000325	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ENO1—stomach cancer	2.86e-05	0.000317	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HBEGF—stomach cancer	2.85e-05	0.000316	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UMPS—stomach cancer	2.82e-05	0.000312	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.81e-05	0.000312	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPP2R1A—stomach cancer	2.72e-05	0.000301	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTP1—stomach cancer	2.67e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—stomach cancer	2.63e-05	0.000291	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PDHA1—stomach cancer	2.62e-05	0.000291	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ECHS1—stomach cancer	2.62e-05	0.000291	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPP2R1A—stomach cancer	2.58e-05	0.000286	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CD44—stomach cancer	2.54e-05	0.000281	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TYMS—stomach cancer	2.48e-05	0.000275	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TYMP—stomach cancer	2.46e-05	0.000273	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FADS1—stomach cancer	2.46e-05	0.000273	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—stomach cancer	2.45e-05	0.000272	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SMAD4—stomach cancer	2.39e-05	0.000265	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SREBF2—stomach cancer	2.31e-05	0.000256	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ERCC2—stomach cancer	2.3e-05	0.000255	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—RORA—stomach cancer	2.28e-05	0.000253	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FYN—stomach cancer	2.27e-05	0.000252	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERCC2—stomach cancer	2.18e-05	0.000242	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—stomach cancer	2.16e-05	0.00024	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPP2R1A—stomach cancer	2.16e-05	0.000239	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDOB—stomach cancer	2.14e-05	0.000237	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGFR2—stomach cancer	2.13e-05	0.000236	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTP1—stomach cancer	2.12e-05	0.000235	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—stomach cancer	2.09e-05	0.000231	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—stomach cancer	2.05e-05	0.000228	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.01e-05	0.000223	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.01e-05	0.000223	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAV1—stomach cancer	2e-05	0.000221	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA1—stomach cancer	1.99e-05	0.000221	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALOX5—stomach cancer	1.99e-05	0.00022	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TYMS—stomach cancer	1.97e-05	0.000218	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DPYD—stomach cancer	1.95e-05	0.000217	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IRS2—stomach cancer	1.95e-05	0.000216	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—stomach cancer	1.94e-05	0.000216	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.91e-05	0.000212	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CAV1—stomach cancer	1.89e-05	0.00021	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOA1—stomach cancer	1.89e-05	0.000209	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ERCC2—stomach cancer	1.83e-05	0.000203	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6ST—stomach cancer	1.79e-05	0.000199	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.77e-05	0.000196	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—stomach cancer	1.76e-05	0.000195	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTT1—stomach cancer	1.73e-05	0.000192	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APC—stomach cancer	1.72e-05	0.000191	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—stomach cancer	1.72e-05	0.000191	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.71e-05	0.000189	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.66e-05	0.000184	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENO1—stomach cancer	1.62e-05	0.000179	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6R—stomach cancer	1.6e-05	0.000177	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.59e-05	0.000177	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAV1—stomach cancer	1.59e-05	0.000176	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA1—stomach cancer	1.58e-05	0.000175	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—stomach cancer	1.58e-05	0.000175	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.51e-05	0.000168	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—stomach cancer	1.51e-05	0.000167	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SERPINE1—stomach cancer	1.5e-05	0.000166	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RHOA—stomach cancer	1.45e-05	0.00016	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CD44—stomach cancer	1.44e-05	0.000159	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—stomach cancer	1.43e-05	0.000159	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—stomach cancer	1.39e-05	0.000155	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.39e-05	0.000154	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—stomach cancer	1.38e-05	0.000153	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB2—stomach cancer	1.34e-05	0.000148	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—stomach cancer	1.25e-05	0.000139	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1B—stomach cancer	1.24e-05	0.000137	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.22e-05	0.000135	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—stomach cancer	1.2e-05	0.000133	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTP1—stomach cancer	1.2e-05	0.000133	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—stomach cancer	1.18e-05	0.000131	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1A—stomach cancer	1.14e-05	0.000127	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TYMS—stomach cancer	1.11e-05	0.000123	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—stomach cancer	1.1e-05	0.000122	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ERCC2—stomach cancer	1.03e-05	0.000115	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—stomach cancer	1.02e-05	0.000113	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK3—stomach cancer	9.75e-06	0.000108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—stomach cancer	9.72e-06	0.000108	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MYC—stomach cancer	9.49e-06	0.000105	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK1—stomach cancer	9.28e-06	0.000103	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGFR—stomach cancer	9.28e-06	0.000103	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAV1—stomach cancer	8.97e-06	9.95e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA1—stomach cancer	8.95e-06	9.92e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KRAS—stomach cancer	8.77e-06	9.72e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.57e-06	9.5e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CA—stomach cancer	8.5e-06	9.42e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CA—stomach cancer	8.05e-06	8.93e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—stomach cancer	7.89e-06	8.74e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HRAS—stomach cancer	7.45e-06	8.26e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—stomach cancer	7.13e-06	7.91e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—stomach cancer	7.09e-06	7.86e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—stomach cancer	6.78e-06	7.52e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CA—stomach cancer	6.74e-06	7.48e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—stomach cancer	6.2e-06	6.88e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CA—stomach cancer	3.82e-06	4.23e-05	CbGpPWpGaD
